Genetic and serum biomarker evidence for a relationship between TNFα and PTSD in Vietnam war combat veterans

Comprehensive Psychiatry

Volumn 74, Issue , 2017, Pages 125-133

  Bruenig, Dagmar ^a,b   Mehta, Divya ^a   Morris, Charles P ^a   Harvey, Wendy ^b   Lawford, Bruce ^a   Young, Ross McD ^a   Voisey, Joanne ^a  

^a QUEENSLAND UNIVERSITY OF TECHNOLOGY   (Australia)

^b GREENSLOPES PRIVATE HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; TUMOR NECROSIS FACTOR; GENETIC MARKER;

AGED; ARTICLE; CASE CONTROL STUDY; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; GENETIC ASSOCIATION; GENETIC MARKER; HUMAN; MAJOR CLINICAL STUDY; MALE; POSTTRAUMATIC STRESS DISORDER; PSYCHOTRAUMA; SINGLE NUCLEOTIDE POLYMORPHISM; VETERAN; WAR; AUSTRALIA; BLOOD; COMBAT DISORDERS; GENETIC POLYMORPHISM; GENETICS; MIDDLE AGED; PSYCHOLOGY; SEVERITY OF ILLNESS INDEX; STRESS DISORDERS, POST-TRAUMATIC;

AGED; AUSTRALIA; BIOMARKERS; CASE-CONTROL STUDIES; COHORT STUDIES; COMBAT DISORDERS; GENETIC MARKERS; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; SEVERITY OF ILLNESS INDEX; STRESS DISORDERS, POST-TRAUMATIC; TUMOR NECROSIS FACTOR-ALPHA; VETERANS; VIETNAM CONFLICT;

EID: 85012306158     PISSN: 0010440X     EISSN: 15328384     Source Type: Journal    
DOI: 10.1016/j.comppsych.2017.01.015     Document Type: Article

References (47)

1. [1] American Psychiatric Association, APA, Diagnostic and statistical manual of mental disorders, fifth edition (dsm-5**). [1 online resource (992 p.)]. Available from: http://qut.eblib.com.au/patron/FullRecord.aspx?p=1811753, 2013.
2. [2] Dohrenwend, B.P., Turner, J.B., Turse, N.A., Adams, B.G., Koenen, K.C., Marshall, R., The psychological risks of Vietnam for u.S. veterans: a revisit with new data and methods. Science 313:5789 (2006), 979–982.
3. [3] Hoge, C.W., Castro, C.A., Messer, S.C., McGurk, D., Cotting, D.I., Koffman, R.L., Combat duty in Iraq and Afghanistan, mental health problems, and barriers to care. N Engl J Med 351:1 (2004), 13–22.
4. [4] Australian Government, DoVA, Vietnam veterans family study (vvfs). Accessed 02.12.2014 2014; Available from: http://www.dva.gov.au/health-and-wellbeing/research-and-development/health-studies/vietnam-veterans-family-study, 2014.
5. [5] Edmondson, D., Kronish, I.M., Shaffer, J.A., Falzon, L., Burg, M.M., Posttraumatic stress disorder and risk for coronary heart disease: a meta-analytic review. Am Heart J 166:5 (2013), 806–814.
6. [6] Wolf, E.J., Bovin, M.J., Green, J.D., Mitchell, K.S., Stoop, T.B., Barretto, K.M., et al. Longitudinal associations between post-traumatic stress disorder and metabolic syndrome severity. Psychol Med 46:10 (2016), 2215–2226.
7. [7] Lee, Y.C., Agnew-Blais, J., Malspeis, S., Keyes, K., Costenbader, K., Kubzansky, L.D., et al. Post-traumatic stress disorder and risk for incident rheumatoid arthritis. Arthritis Care Res (Hoboken) 68:3 (2016), 292–298.
8. [8] Stein, M.B., Chen, C.Y., Ursano, R.J., Cai, T., Gelernter, J., Heeringa, S.G., et al. Genome-wide association studies of posttraumatic stress disorder in 2 cohorts of us army soldiers. JAMA Psychiatry 73:7 (2016), 695–704.
9. [9] Leonard, B., Maes, M., Mechanistic explanations how cell-mediated immune activation, inflammation and oxidative and nitrosative stress pathways and their sequels and concomitants play a role in the pathophysiology of unipolar depression. Neurosci Biobehav Rev 36:2 (2012), 764–785.
10. [10] Lindqvist, D., Dhabhar, F.S., Mellon, S.H., Yehuda, R., Grenon, S.M., Flory, J.D., et al. Increased pro-inflammatory milieu in combat related ptsd - a new cohort replication study. Brain Behav Immun, 2016, 10.1016/j.bbi.2016.09.012.
11. [11] Lindqvist, D., Wolkowitz, O.M., Mellon, S., Yehuda, R., Flory, J.D., Henn-Haase, C., et al. Proinflammatory milieu in combat-related ptsd is independent of depression and early life stress. Brain Behav Immun 42 (2014), 81–88.
12. [12] Groer, M.W., Kane, B., Williams, S.N., Duffy, A., Relationship of ptsd symptoms with combat exposure, stress, and inflammation in american soldiers. Biol Res Nurs 17:3 (2015), 303–310.
13. [13] O'Donovan, A., Chao, L.L., Paulson, J., Samuelson, K.W., Shigenaga, J.K., Grunfeld, C., et al. Altered inflammatory activity associated with reduced hippocampal volume and more severe posttraumatic stress symptoms in gulf war veterans. Psychoneuroendocrinology 51 (2015), 557–566.
14. [14] Eraly, S.A., Nievergelt, C.M., Maihofer, A.X., Barkauskas, D.A., Biswas, N., Agorastos, A., et al. Assessment of plasma c-reactive protein as a biomarker of posttraumatic stress disorder risk. JAMA Psychiatry 71:4 (2014), 423–431.
15. [15] Plantinga, L., Bremner, J.D., Miller, A.H., Jones, D.P., Veledar, E., Goldberg, J., et al. Association between posttraumatic stress disorder and inflammation: a twin study. Brain Behav Immun 30 (2013), 125–132.
16. [16] Powers, A., Almli, L., Smith, A., Lori, A., Leveille, J., Ressler, K.J., et al. A genome-wide association study of emotion dysregulation: evidence for interleukin 2 receptor alpha. J Psychiatr Res 83 (2016), 195–202.
17. [17] Kim, Y.K., Na, K.S., Shin, K.H., Jung, H.Y., Choi, S.H., Kim, J.B., Cytokine imbalance in the pathophysiology of major depressive disorder. Prog Neuro-Psychopharmacol Biol Psychiatry 31:5 (2007), 1044–1053.
18. [18] Rasheed, H., El-Komy, M., Hegazy, R.A., Gawdat, H.I., AlOrbani, A.M., Shaker, O.G., Expression of sirtuins 1, 6, tumor necrosis factor, and interferon-gamma in psoriatic patients. Int J Immunopathol Pharmacol, 2016, 10.1177/0394632016662475.
19. [19] Kroeger, K.M., Carville, K.S., Abraham, L.J., The −308 tumor necrosis factor-alpha promoter polymorphism effects transcription. Mol Immunol 34:5 (1997), 391–399.
20. [20] Wilson, A.G., de Vries, N., Pociot, F., di Giovine, F.S., van der Putte, L.B., Duff, G.W., An allelic polymorphism within the human tumor necrosis factor alpha promoter region is strongly associated with hla a1, b8, and dr3 alleles. J Exp Med 177:2 (1993), 557–560.
21. [21] D'Alfonso, S., Richiardi, P.M., A polymorphic variation in a putative regulation box of the tnfa promoter region. Immunogenetics 39:2 (1994), 150–154.
22. [22] Song, G.G., Bae, S.-C., Kim, J.-H., Lee, Y.H., Association between tnf-[alpha] promoter −308 a/g polymorphism and rheumatoid arthritis: a meta-analysis. Rheumatol Int 34:4 (2014), 465–471.
23. [23] Chae, J.W., Ng, T., Yeo, H.L., Shwe, M., Gan, Y.X., Ho, H.K., et al. Impact of tnf-alpha (rs1800629) and il-6 (rs1800795) polymorphisms on cognitive impairment in asian breast cancer patients. PLoS One, 11(10), 2016, e0164204.
24. [24] Barnes, J., Mondelli, V., Pariante, C.M., Genetic contributions of inflammation to depression. Neuropsychopharmacology, 2016, 10.1038/npp.2016.169.
25. [25] Sutcigil, L., Oktenli, C., Musabak, U., Bozkurt, A., Cansever, A., Uzun, O., et al. Pro- and anti-inflammatory cytokine balance in major depression: effect of sertraline therapy. Clin Dev Immunol, 2007, 2007, 76396.
26. [26] Ertenli, I., Ozer, S., Kiraz, S., Apras, S.B., Akdogan, A., Karadag, O., et al. Infliximab, a tnf-alpha antagonist treatment in patients with ankylosing spondylitis: the impact on depression, anxiety and quality of life level. Rheumatol Int 32:2 (2012), 323–330.
27. [27] Uguz, F., Akman, C., Kucuksarac, S., Tufekci, O., Anti-tumor necrosis factor-alpha therapy is associated with less frequent mood and anxiety disorders in patients with rheumatoid arthritis. Psychiatry Clin Neurosci 63:1 (2009), 50–55.
28. [28] Fu, X.Y., Li, H.Y., Jiang, Q.S., Cui, T., Jiang, X.H., Zhou, Q.X., et al. Infliximab ameliorating depression-like behavior through inhibiting the activation of the ido-haao pathway mediated by tumor necrosis factor-alpha in a rat model. Neuroreport 27:13 (2016), 953–959.
29. [29] Raison, C.L., Rutherford, R.E., Woolwine, B.J., Shuo, C., Schettler, P., Drake, D.F., et al. A randomized controlled trial of the tumor necrosis factor antagonist infliximab for treatment-resistant depression: the role of baseline inflammatory biomarkers. JAMA Psychiatry 70:1 (2013), 31–41.
30. [30] Moreira, F.P., Cardoso Tde, A., Mondin, T.C., Souza, L.D., Silva, R., Jansen, K., et al. The effect of proinflammatory cytokines in cognitive behavioral therapy. J Neuroimmunol 285 (2015), 143–146.
31. [31] Ma, K., Zhang, H., Baloch, Z., Pathogenetic and therapeutic applications of tumor necrosis factor-α (tnf-α) in major depressive disorder: a systematic review. Int J Mol Sci, 17(5), 2016, 733.
32. [32] Del Grande da Silva, G., Wiener, C.D., Barbosa, L.P., Gonçalves Araujo, J.M., Molina, M.L., San Martin, P., et al. Pro-inflammatory cytokines and psychotherapy in depression: results from a randomized clinical trial. J Psychiatr Res 75 (2016), 57–64.
33. [33] Gola, H., Engler, H., Sommershof, A., Adenauer, H., Kolassa, S., Schedlowski, M., et al. Posttraumatic stress disorder is associated with an enhanced spontaneous production of pro-inflammatory cytokines by peripheral blood mononuclear cells. BMC Psychiatry, 13, 2013, 40.
34. [34] von Kanel, R., Hepp, U., Kraemer, B., Traber, R., Keel, M., Mica, L., et al. Evidence for low-grade systemic proinflammatory activity in patients with posttraumatic stress disorder. J Psychiatr Res 41:9 (2007), 744–752.
35. [35] Guo, M., Liu, T., Guo, J.C., Jiang, X.L., Chen, F., Gao, Y.S., Study on serum cytokine levels in posttraumatic stress disorder patients. Asian Pac J Trop Med 5:4 (2012), 323–325.
36. [36] Passos, I.C., Vasconcelos-Moreno, M.P., Costa, L.G., Kunz, M., Brietzke, E., Quevedo, J., et al. Inflammatory markers in post-traumatic stress disorder: a systematic review, meta-analysis, and meta-regression. Lancet Psychiatry 2:11 (2015), 1002–1012.
37. [37] Gill, J.M., Saligan, L., Lee, H., Rotolo, S., Szanton, S., Corrigendum to women in recovery from ptsd have similar inflammation and quality of life as non-traumatized controls [j psychosom res 74 (2013) 301-306]. J Psychosom Res, 75(1), 2013, 92.
38. [38] Kohrt, B.A., Worthman, C.M., Adhikari, R.P., Luitel, N.P., Arevalo, J.M.G., Ma, J., et al. Psychological resilience and the gene regulatory impact of posttraumatic stress in Nepali child soldiers. Proc Natl Acad Sci 113:29 (2016), 8156–8161.
39. [39] Weathers, F.W., Marx, B.P., Friedman, M.J., Schnurr, P.P., Posttraumatic stress disorder in dsm-5: new criteria, new measures, and implications for assessment. Psychol Inj Law 7:2 (2014), 93–107.
40. [40] Connor, K.M., Davidson, J.R.T., Development of a new resilience scale: the connor-Davidson resilience scale (cd-risc). Depress Anxiety 18:2 (2003), 76–82.
41. [41] Bezdjian, S., Schneider, K.G., Burchett, D., Baker, M.T., Garb, H.N., Resilience in the United States air force: psychometric properties of the Connor-Davidson resilience scale (cd-risc). Psychol Assess, 2016, 10.1037/pas0000370.
42. [42] Sheehan, D.V., Lecrubier, Y., Sheehan, K.H., Amorim, P., Janavs, J., Weiller, E., et al. The mini-international neuropsychiatric interview (m.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for dsm-iv and icd-10. J Clin Psychiatry 59:Suppl. 20 (1998), 22–33 [quiz 34–57].
43. [43] Lovibond, S.H., Lovibond, P.F., The structure of negative emotional states: comparison of the depression anxiety stress scales (dass) with the beck depression and anxiety inventories. Behav Res Ther 33:3 (1995), 335–343.
44. [44] Ott, J., Utility programs for analysis of genetic linkage. Program. Hwe version 1.10. 1988, Columbia University, New York.
45. [45] Ibm spss statistics for windows. 2015, IBM Corp., Armonk, NY.
46. [46] Cui, G., Wang, H., Li, R., Zhang, L., Li, Z., Wang, Y., et al. Polymorphism of tumor necrosis factor alpha (tnf-alpha) gene promoter, circulating tnf-alpha level, and cardiovascular risk factor for ischemic stroke. J Neuroinflammation, 9, 2012, 235.
47. [47] Wagnild, G.M., Young, H.M., Development and psychometric evaluation of the resilience scale. J Nurs Meas 1:2 (1993), 165–178.